Possible Action of Olaparib for Preventing Invasion of Oral Squamous Cell Carcinoma In Vitro and In Vivo

Despite recent advances in treatment, the prognosis of oral cancer remains poor, and prevention of recurrence and metastasis is critical. Olaparib is a PARP1 inhibitor that blocks polyADP-ribosylation, which is involved in the epithelial–mesenchymal transition (EMT) characteristic of tumor recurrenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Nanami, Fujihara, Hisako, Kawaguchi, Koji, Yamada, Hiroyuki, Nakayama, Ryoko, Yasukawa, Masaaki, Kishi, Yuta, Hamada, Yoshiki, Masutani, Mitsuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909974/
https://www.ncbi.nlm.nih.gov/pubmed/35269669
http://dx.doi.org/10.3390/ijms23052527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909974/
https://www.ncbi.nlm.nih.gov/pubmed/35269669
http://dx.doi.org/10.3390/ijms23052527

Ejemplares similares